Investigational anti-amyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Shelby Tungate Lopez, PharmD, CPP, BCACP, MPA
Advertisement
Articles by Shelby Tungate Lopez, PharmD, CPP, BCACP, MPA
Craig Beavers discusses recent developments in hypertension management and the clinical implications of the Bax Hypertension and KARDIA-3 trials with Shelby Tungate from the UNC Eshelman School of Pharmacy.
Advertisement
Latest Updated Articles
KARDIA-3 Versus Cardia: New Frontiers in Hypertension CareOctober 7th 2025
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
FDA Grants Accelerated Approval to Ravulizumab for Proteinuria Reduction in IgA Nephropathy
4
What Pharmacists Should Know About Sea Buckthorn for Respiratory Health
5